Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 1/10

vs
industry
vs
history
Cash to Debt 0.39
CATS's Cash to Debt is ranked higher than
53% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. CATS: 0.39 )
Ranked among companies with meaningful Cash to Debt only.
CATS' s 10-Year Cash to Debt Range
Min: 0.06   Max: No Debt
Current: 0.39

Equity to Asset -30.19
CATS's Equity to Asset is ranked lower than
100% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. CATS: -30.19 )
Ranked among companies with meaningful Equity to Asset only.
CATS' s 10-Year Equity to Asset Range
Min: -30.19   Max: 0.94
Current: -30.19

-30.19
0.94
F-Score: 5
Z-Score: -336.60
M-Score: -11.24
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -309.19
CATS's Operating margin (%) is ranked lower than
100% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 7.51 vs. CATS: -309.19 )
Ranked among companies with meaningful Operating margin (%) only.
CATS' s 10-Year Operating margin (%) Range
Min: -6221.35   Max: 0.84
Current: -309.19

-6221.35
0.84
Net-margin (%) -1313.83
CATS's Net-margin (%) is ranked lower than
100% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 3.31 vs. CATS: -1313.83 )
Ranked among companies with meaningful Net-margin (%) only.
CATS' s 10-Year Net-margin (%) Range
Min: -6132.81   Max: 0.84
Current: -1313.83

-6132.81
0.84
ROA (%) -1386.20
CATS's ROA (%) is ranked lower than
100% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 3.44 vs. CATS: -1386.20 )
Ranked among companies with meaningful ROA (%) only.
CATS' s 10-Year ROA (%) Range
Min: -1099.34   Max: -30.42
Current: -1386.2

-1099.34
-30.42
ROC (Joel Greenblatt) (%) -1943.36
CATS's ROC (Joel Greenblatt) (%) is ranked lower than
99% of the 207 Companies
in the Global Medical Care industry.

( Industry Median: 14.26 vs. CATS: -1943.36 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CATS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -12920.27   Max: -352.04
Current: -1943.36

-12920.27
-352.04
Revenue Growth (3Y)(%) -13.70
CATS's Revenue Growth (3Y)(%) is ranked lower than
88% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. CATS: -13.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CATS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -85.3   Max: 399.3
Current: -13.7

-85.3
399.3
EBITDA Growth (3Y)(%) -24.20
CATS's EBITDA Growth (3Y)(%) is ranked lower than
93% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. CATS: -24.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CATS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -79.7   Max: 153.7
Current: -24.2

-79.7
153.7
EPS Growth (3Y)(%) -35.00
CATS's EPS Growth (3Y)(%) is ranked lower than
88% of the 111 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. CATS: -35.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CATS' s 10-Year EPS Growth (3Y)(%) Range
Min: -87   Max: 151.4
Current: -35

-87
151.4
» CATS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with CATS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 14.40
CATS's P/S is ranked lower than
119% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 3.87 vs. CATS: 14.40 )
Ranked among companies with meaningful P/S only.
CATS' s 10-Year P/S Range
Min: 0.44   Max: 1210.74
Current: 14.4

0.44
1210.74
Current Ratio 0.15
CATS's Current Ratio is ranked lower than
98% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. CATS: 0.15 )
Ranked among companies with meaningful Current Ratio only.
CATS' s 10-Year Current Ratio Range
Min: 0.11   Max: 15.93
Current: 0.15

0.11
15.93
Quick Ratio 0.15
CATS's Quick Ratio is ranked lower than
98% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. CATS: 0.15 )
Ranked among companies with meaningful Quick Ratio only.
CATS' s 10-Year Quick Ratio Range
Min: 0.11   Max: 15.93
Current: 0.15

0.11
15.93
Days Sales Outstanding 17.57
CATS's Days Sales Outstanding is ranked higher than
83% of the 185 Companies
in the Global Medical Care industry.

( Industry Median: 46.90 vs. CATS: 17.57 )
Ranked among companies with meaningful Days Sales Outstanding only.
CATS' s 10-Year Days Sales Outstanding Range
Min: 14.36   Max: 2214.33
Current: 17.57

14.36
2214.33

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.80
CATS's Price/Median PS Value is ranked higher than
91% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. CATS: 0.80 )
Ranked among companies with meaningful Price/Median PS Value only.
CATS' s 10-Year Price/Median PS Value Range
Min: 0.05   Max: 54.55
Current: 0.8

0.05
54.55
Earnings Yield (Greenblatt) -20.30
CATS's Earnings Yield (Greenblatt) is ranked lower than
97% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 4.30 vs. CATS: -20.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
CATS' s 10-Year Earnings Yield (Greenblatt) Range
Min: -23.9   Max: 0
Current: -20.3

-23.9
0

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Catasys Inc is a healthcare services company, providing specialized health services designed to assist health plans and other third-party payors to manage and treat their high cost substance dependence members through a network of healthcare providers and its employees. The OnTrak substance dependence program was designed to address substance dependence as a chronic disease. The program seeks improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching. It operates in two segments: Healthcare Services and License & Management Services. It operates in Kansas, Massachusetts, Louisiana, Oklahoma, Kentucky, West Virginia, and Wisconsin. The Company competes with Hummingbird, One Health Solutions, and Health Integrated. It also competes with other healthcare management service organizations, including managed behavioral health organizations. It owns trademarks for onTrak and eOnTrak.
» More Articles for CATS

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
CATASYS, INC. Financials May 27 2015
Catasys Announces Warrant Exchange for Common Stock May 20 2015
CATASYS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... May 20 2015
Catasys Announces Warrant Exchange for Common Stock May 20 2015
CATASYS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 18 2015
Catasys Announces First Quarter 2015 Financial Results May 18 2015
Catasys Announces First Quarter 2015 Financial Results May 18 2015
10-Q for Catasys, Inc. May 17 2015
CATASYS, INC. Files SEC form 10-Q, Quarterly Report May 15 2015
Catasys Announces Enrollment of Members with Anxiety Disorder in its OnTrak™ Program in Kansas May 12 2015
Catasys Announces Enrollment of Members with Anxiety Disorder in its OnTrak™ Program in Kansas May 12 2015
Study Shows Improved Health for Participants in Integrated Substance Abuse Program May 04 2015
10-K for Catasys, Inc. Apr 25 2015
Catasys and Health Alliance Medical Plans Announce Contract in Illinoiss Apr 22 2015
Catasys and Health Alliance Medical Plans Announce Contract in Illinois Apr 22 2015
CATASYS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Apr 21 2015
Catasys Reports Full Year 2014 Financial Results Apr 01 2015
CATASYS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 01 2015
Catasys Reports Full Year 2014 Financial Results Apr 01 2015
CATASYS, INC. Files SEC form 10-K, Annual Report Mar 31 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK